| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040641632 |
| P356 | DOI | 10.1038/297474A0 |
| P953 | full work available at URL | http://www.nature.com/articles/297474a0 |
| http://www.nature.com/articles/297474a0.pdf | ||
| P698 | PubMed publication ID | 6283357 |
| P2093 | author name string | L. F. Parada | |
| R. A. Weinberg | |||
| C. Shih | |||
| C. J. Tabin | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I | Q27860885 | ||
| Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates | Q28776303 | ||
| Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate | Q29618203 | ||
| Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus | Q33917969 | ||
| Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin | Q33980315 | ||
| Human-tumor-derived cell lines contain common and different transforming genes | Q34245850 | ||
| Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus | Q34253429 | ||
| AN UNIDENTIFIED VIRUS WHICH CAUSES THE RAPID PRODUCTION OF TUMOURS IN MICE. | Q34258782 | ||
| Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells | Q34277765 | ||
| DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA | Q34581419 | ||
| Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells | Q35242577 | ||
| Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus | Q35371969 | ||
| Transforming activity of human tumor DNAs | Q35426142 | ||
| Activation of related transforming genes in mouse and human mammary carcinomas | Q35469217 | ||
| DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster | Q36377947 | ||
| High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice | Q36383218 | ||
| DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. | Q36396364 | ||
| Molecular cloning and characterization of avian sarcoma virus circular DNA molecules | Q36506123 | ||
| Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus | Q36507362 | ||
| Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells | Q36507789 | ||
| Endogenous oncornaviruses in chemically induced transformation. I. Transformation independent of virus production | Q39930480 | ||
| Proposal for Naming Host Cell-Derived Inserts in Retrovirus Genomes | Q40144761 | ||
| Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus | Q40241805 | ||
| Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture | Q40512568 | ||
| Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts | Q42801594 | ||
| Three different human tumor cell lines contain different oncogenes | Q43550250 | ||
| Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA | Q45802663 | ||
| Clonal cell lines from the rat central nervous system. | Q52827117 | ||
| The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes | Q53570306 | ||
| Retroviruses as mutagens: Insertion and excision of a nontransforming provirus alter expression of a resident transforming provirus | Q53570869 | ||
| Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry | Q53577737 | ||
| Unique transforming gene in carcinogen-transformed mouse cells | Q59064828 | ||
| In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2 | Q111841201 | ||
| P433 | issue | 5866 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| bladder carcinoma | Q18556149 | ||
| viral genes | Q71237937 | ||
| P304 | page(s) | 474-478 | |
| P577 | publication date | 1982-06-01 | |
| 1982-06-10 | |||
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene | |
| P478 | volume | 297 |
| Q37408568 | A GTP-binding protein of Escherichia coli has homology to yeast RAS proteins |
| Q42819141 | A Transforming ras Gene in Tumorigenic Guinea Pig Cell Lines Initiated by Diverse Chemical Carcinogens |
| Q57382481 | A cellular oncogene (c-Ki-ras) is amplified, overexpressed and located within karyotypic abnormalities in mouse adrenocortical tumour cells |
| Q59080605 | A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia |
| Q98303321 | A compendium of mutational cancer driver genes |
| Q35765790 | A genotypic mutation system measuring mutations in restriction recognition sequences. |
| Q36245581 | A molecular approach to leukemogenesis: mouse lymphomas contain an activated c-ras oncogene |
| Q37898108 | A new frontier in personalized cancer therapy: mapping molecular changes. |
| Q36911465 | A new oncogene, c-raf, is located on mouse chromosome 6. |
| Q24650249 | A new view of carcinogenesis and an alternative approach to cancer therapy |
| Q42817664 | A novel transforming gene in a human malignant melanoma cell line |
| Q28279136 | A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene |
| Q37565544 | A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient |
| Q27929849 | A product of yeast RAS2 gene is a guanine nucleotide binding protein |
| Q36766046 | A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene |
| Q41726056 | A transforming Kirsten ras oncogene in an oral squamous carcinoma |
| Q28264768 | A transforming gene present in human sarcoma cell lines |
| Q35951892 | A virtual pyrogram generator to resolve complex pyrosequencing results |
| Q37085887 | ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer |
| Q39561478 | ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein |
| Q28275191 | Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene |
| Q38222722 | Activated K-RAS and its effect on morphological appearance. |
| Q36917943 | Activated K-ras and N-ras oncogenes in primary renal mesenchymal tumors induced in F344 rats by methyl(methoxymethyl)nitrosamine |
| Q36782441 | Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life |
| Q48396942 | Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations |
| Q42819366 | Activation of N-ras gene in bone marrow cells from a patient with acute myeloblastic leukaemia |
| Q24618187 | Activation of N-ras in a human melanoma cell line |
| Q48401500 | Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element |
| Q24568201 | Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon |
| Q34280682 | Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. |
| Q40237699 | Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas |
| Q37113394 | Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism |
| Q42832911 | Alterations of mouse proto-oncogenes in sarcomas induced after transplantation of human tumors in athymic nude mice |
| Q36904343 | Analysis of viral and somatic activations of the cHa-ras gene |
| Q70490940 | Anatomy of a human cancer gene |
| Q33761930 | Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3 |
| Q53542695 | Anti-oncogenes. A subset of regulatory genes involved in carcinogenesis? |
| Q37204679 | Applications of genomics in melanoma oncogene discovery |
| Q70182304 | Assignment of murine cellular HarveyRas gene to chromosome 7 |
| Q35068684 | AtROP1 negatively regulates potato resistance to Phytophthora infestans via NADPH oxidase-mediated accumulation of H2O2. |
| Q36952471 | Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene |
| Q52827198 | BALB and kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocyte lines |
| Q39637771 | Back to the future: host-targeted chemotherapeutics for drug-resistant TB. |
| Q36915093 | Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts |
| Q69194909 | Benzo[a]pyrene-diol-epoxide-induced anchorage-independence in diploid human fibroblasts. Analysis of cellular protooncogenes |
| Q40658346 | Biochemical and biological properties of the human N-ras p21 protein |
| Q39819264 | Biological and molecular analysis of p53 cellular-encoded tumor antigen |
| Q42817584 | Biological properties of human c-Ha-ras1 genes mutated at codon 12. |
| Q36466131 | Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe |
| Q28085552 | Cancer Genome Atlas Pan-cancer Analysis Project |
| Q40778155 | Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis |
| Q34253580 | Cancer genetics. |
| Q37148184 | Cancer genome sequencing and its implications for personalized cancer vaccines |
| Q26828818 | Cancer: we should not forget the past |
| Q40161805 | Cellular Oncogenes and Multistep Carcinogenesis |
| Q34253517 | Cellular Transforming Genes |
| Q36047485 | Cellular heterogeneity in a tissue culture cell line derived from a human bladder carcinoma |
| Q40143538 | Cellular transforming genes and oncogenesis |
| Q24615673 | Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene |
| Q59086201 | Characterization of a human colon/lung carcinoma oncogene |
| Q28211237 | Characterization of the novel amplified in breast cancer-1 (NABC1) gene product |
| Q39820037 | Chemical carcinogenesis: a biochemical overview |
| Q28768656 | Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens |
| Q37343050 | Chromosomal assignment of a family of human oncogenes |
| Q53563938 | Chromosomal localization of human cellular homologues of two viral oncogenes. |
| Q35687862 | Chromosomal localization of the human c-fms oncogene |
| Q34488700 | Clinical Implications of the Cancer Genome |
| Q41571752 | Co-transfection of normal NIH/3T3 DNA and retroval LTR sequences: a novel strategy for the detection of potential c-onc genes |
| Q48399601 | Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue |
| Q36906152 | Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus |
| Q40839640 | Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen |
| Q39581697 | Control of myogenic differentiation by cellular oncogenes |
| Q64240621 | Convergent perturbation of the human domain-resolved interactome by viruses and mutations inducing similar disease phenotypes |
| Q42798594 | Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers. |
| Q41499708 | Coumarin modulates the cell-cycle progression of an MTV-EJras cell line |
| Q40077580 | Current Understanding of Virus Etiology in Leukemia |
| Q34639825 | Cytogenetic and molecular studies on a recombinant human X chromosome: implications for the spreading of X chromosome inactivation |
| Q36839982 | Definition of regions in human c-myc that are involved in transformation and nuclear localization |
| Q72694612 | Depression of reverse transcriptase activity by hybridoma supernatants: A potential problem in screening for retroviral contamination |
| Q52500097 | Detection of a molecular complex between ras proteins and transferrin receptor |
| Q37531654 | Detection of a raf-related and two other transforming DNA sequences in human tumors maintained in nude mice |
| Q36901535 | Development and analysis of a transformation-defective mutant of Harvey murine sarcoma tk virus and its gene product. |
| Q36218963 | Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes |
| Q36536905 | Diagnostic utility of oncogenes and their products in human cancer |
| Q33931394 | Differential methylation of the c-H-ras gene in normal mouse cells and during skin tumour progression |
| Q38911598 | Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design |
| Q73322448 | Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis |
| Q36610990 | Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. |
| Q61809925 | Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction |
| Q43557489 | Dispersion of the ras family of transforming genes to four different chromosomes in man. |
| Q36570897 | Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers |
| Q28282033 | Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies |
| Q37672156 | Effects of two major activating lesions on the structure and conformation of human ras oncogene products |
| Q39026766 | Endometrial Carcinoma: Specific Targeted Pathways. |
| Q35594513 | Enhanced c-Ki-ras expression associated with Friend virus integration in a bone marrow-derived mouse cell line |
| Q42818380 | Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins |
| Q41145938 | Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas |
| Q41662966 | Evaluation of transforming activity of cellular DNAs from different origins by NIH3T3 transfection test |
| Q34245213 | Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins |
| Q37680820 | Expression of p21ras in fresh primary and metastatic human colorectal tumors |
| Q34622969 | Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy |
| Q35925163 | Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions |
| Q33832634 | Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway |
| Q40273505 | Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene |
| Q28218688 | Fortuitous convergences: the beginnings of JUN |
| Q36993193 | Free radicals in chemical carcinogenesis |
| Q37690563 | Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors |
| Q53559358 | Frequent Activation of c- kis as a Transforming Gene in Fibrosarcomas Induced by Methylcholanthrene |
| Q37734603 | Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells |
| Q38557036 | From Ras to Rap and Back, a Journey of 35 Years |
| Q38103175 | Function of oncogenes in cancer development: a changing paradigm |
| Q36698048 | Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression |
| Q41732514 | Functional expression of dihydropyridine-insensitive calcium channels during PC12 cell differentiation by nerve growth factor (NGF), oncogenic ras, or src tyrosine kinase |
| Q36941287 | GTP binding proteins and growth factor signal transduction |
| Q70331629 | GTP dependence of the transduction of mitogenic signals through the T3 complex in T lymphocytes indicates the involvement of a G-protein |
| Q40553433 | Genetic alterations in prostate adenocarcinoma. |
| Q37345944 | Genetic analysis of the 15;17 chromosome translocation associated with acute promyelocytic leukemia |
| Q36906992 | Genetic mapping of the mouse oncogenes c-Ha-ras-1 and c-fes to chromosome 7. |
| Q26853507 | Genomic sequencing in cancer |
| Q37055334 | Genotypic analysis of N-ethyl-N-nitrosourea-induced mutations by Taq I restriction fragment length polymorphism/polymerase chain reaction in the c-H-ras1 gene |
| Q36807860 | Genotypic analysis of mutations in Taq I restriction recognition sites by restriction fragment length polymorphism/polymerase chain reaction |
| Q41966335 | Glucagon and p21 ras enhance the phosphorylation of the same 38-kilodalton membrane protein from rat liver cells |
| Q93045200 | Glycyrrhetinic acid binds to the conserved P-loop region and interferes with the interaction of RAS-effector proteins |
| Q37576661 | Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli. |
| Q42818690 | Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours |
| Q37673948 | Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity |
| Q35598818 | Harvey ras genes transform without mutant codons, apparently activated by truncation of a 5' exon (exon -1) |
| Q36946669 | Human Colon Carcinoma Ki-ras2 Oncogene and Its Corresponding Proto-Oncogene |
| Q24625952 | Human N-ras: cDNA cloning and gene structure |
| Q28350937 | Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion |
| Q36081239 | Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression |
| Q39668510 | Human cancer and cellular oncogenes |
| Q35844971 | Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters |
| Q70339238 | Human oncogenes |
| Q35589281 | Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis |
| Q72691575 | Hypomethylation of ras oncogenes in primary human cancers |
| Q30959617 | Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia |
| Q36597912 | Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas. |
| Q37549894 | Identification by transfection of transforming sequences in DNA of human T-cell leukemias |
| Q33879376 | Identification of a provirally activated c-Ha-ras oncogene in an avian nephroblastoma via a novel procedure: cDNA cloning of a chimaeric viral-host transcript |
| Q28239452 | Identification of cancer genes by mutational profiling of tumor genomes |
| Q34674350 | Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value. |
| Q34254574 | Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. |
| Q42799320 | Identity of some human bladder cancer cell lines |
| Q36600667 | Immunocytochemical localization in normal and transformed human cells in tissue culture using a monoclonal antibody to the src protein of the Harvey strain of Murine Sarcoma Virus |
| Q70247500 | Immunocytochemical localization of ras p21 product in thyroid follicular cells of normal rats using monoclonal antibody RAP-5 |
| Q37205435 | Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man. |
| Q41790358 | Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms |
| Q42840349 | Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9. |
| Q39323703 | In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance |
| Q53561093 | In vivo induction of neoplastic growth in nude mouse connective tissue adjacent to xenografted human tumors. |
| Q53556700 | Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. |
| Q36269129 | Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity |
| Q36787138 | Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest |
| Q36900547 | Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes. |
| Q36872298 | Insufficiency of transformation by simian virus 40, polyomavirus, EJ-ras, or v-myc oncogenes for conversion of ethanolamine-responsive mammary cells to ethanolamine-nonresponsive cells |
| Q36267430 | Isolation and characterization of a stage-specific transforming gene, Tlym-I, from T-cell lymphomas |
| Q28265250 | Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line |
| Q24618042 | Isolation of duplicated human c-src genes located on chromosomes 1 and 20 |
| Q30830920 | Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras |
| Q36244681 | Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes. |
| Q36597411 | Isolation of v-fms and its human cellular homolog |
| Q40434681 | K-ras mutation and pancreatic adenocarcinoma |
| Q37815135 | KRAS and BRAF: drug targets and predictive biomarkers |
| Q39584798 | KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas |
| Q49887897 | KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target |
| Q44787618 | Karyotype and ultrastructure of a colony stimulating factor (CSF) producing cell line (5637) originated from a carcinoma of the human urinary bladder |
| Q26751212 | Kirsten Ras* oncogene: Significance of its discovery in human cancer research |
| Q38956084 | Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective. |
| Q44744942 | Localization of H-ras mRNA in oral squamous cell carcinomas |
| Q37344757 | Localization of c-ras oncogene family on human germ-line chromosomes |
| Q44611368 | Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11. |
| Q37537053 | Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen |
| Q33846850 | Making sense of cancer genomic data |
| Q38642874 | Malignant transformation of mammalian cells in culture, including human cells |
| Q40667295 | Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor |
| Q37056216 | Many roads lead to oncogene-induced senescence |
| Q29616165 | Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome |
| Q34708285 | Mechanism of activation of a human oncogene |
| Q24555646 | Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080 |
| Q24595622 | Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells |
| Q36946976 | Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs |
| Q35708595 | Methotrexate and Ras methylation: a new trick for an old drug? |
| Q34613693 | Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally |
| Q33599411 | MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion |
| Q58718486 | MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS |
| Q38548766 | MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer |
| Q38258795 | Milestones in skin carcinogenesis: the biology of multistage carcinogenesis |
| Q35187767 | Model systems in drug discovery: chemical genetics meets genomics |
| Q34514709 | Models of carcinogenesis: an overview |
| Q45838926 | Modulation of adenylate cyclase by guanine nucleotides and Kirsten sarcoma virus mediated transformation |
| Q36844208 | Modulation of transforming growth factor type beta action by activated ras and c-myc |
| Q41512807 | Molecular analysis of rat embryo cell transformants induced by alpha-particles |
| Q40896939 | Molecular basis of cancer: oncogenes and tumor suppressor genes |
| Q35266400 | Molecular biology of bladder cancer |
| Q40659244 | Molecular cloning and characterization of an activated human c-raf-1 gene |
| Q35436153 | Molecular cloning and chromosome assignment of murine N-ras |
| Q48399510 | Molecular cloning and nucleotide sequence of a transforming gene detected by transfection of chicken B-cell lymphoma DNA. |
| Q33931037 | Molecular cloning and sequence analysis of a ras gene from Schizosaccharomyces pombe |
| Q37529389 | Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer |
| Q35616027 | Molecular cloning of an oncogene from a human hepatocellular carcinoma |
| Q30486859 | Molecular genetic aspects of human cancers: the 1993 Frank Rose Lecture |
| Q35917589 | Molecular medicine: a clinician's primer on microarrays. |
| Q36249264 | Molecular pathology of prostate cancer. |
| Q42817693 | Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases |
| Q36976043 | Mouse Cells Contain Two Distinct ras Gene mRNA Species That Can Be Translated into a p21 onc Protein |
| Q42823403 | Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene |
| Q40951665 | Mutation and cancer: a personal odyssey |
| Q37512938 | Mutation-associated fusion cancer genes in solid tumors. |
| Q37421430 | Mutational spectra of human cancer. |
| Q53380748 | Neonatal lethal Costello syndrome and unusual dinucleotide deletion/insertion mutations in HRAS predicting p.Gly12Val. |
| Q53798374 | Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis. |
| Q36947151 | New Human Transforming Genes Detected by a Tumorigenicity Assay |
| Q36885249 | New acceptor cell for transfected genomic DNA: oncogene transfer into a mouse mammary epithelial cell line |
| Q38493823 | New and promising strategies in the management of bladder cancer. |
| Q66679281 | New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies |
| Q37671224 | New insights into the causes of cancer. |
| Q36931107 | New mammalian transforming retrovirus: demonstration of a polyprotein gene product |
| Q51032285 | Next-Generation Sequencing. |
| Q43506385 | No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases |
| Q37610817 | Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer |
| Q26823718 | Noncoding RNA in oncogenesis: a new era of identifying key players |
| Q45796114 | Nucleotide Sequence of the Rasheed Rat Sarcoma Virus Oncogene: New Mutations |
| Q36899738 | Nucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene |
| Q36914194 | Nucleotide sequence of the two rat cellular rasH genes |
| Q59071123 | Onco gen: Human oncogene locations and chromosome aberrations |
| Q39559546 | Oncogene activation in chemical carcinogenesis |
| Q67261188 | Oncogene from Human EJ Bladder Carcinoma Is Located on the Short Arm of Chromosome 11 |
| Q40203216 | Oncogene research: closing in on a better understanding of cancer causation |
| Q40179507 | Oncogenes and Cancer: The p21rasGenes |
| Q45785150 | Oncogenes and Retroviruses: Evaluation of Basic Findings and Clinical Potential |
| Q36874460 | Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour |
| Q40169999 | Oncogenes and cancer |
| Q44714658 | Oncogenes and cancer |
| Q39642389 | Oncogenes and gastrointestinal cancer |
| Q41434398 | Oncogenes and the molecular biology of cancer |
| Q53558210 | Oncogenes in retroviruses and cells |
| Q28279392 | Oncogenes in solid human tumours |
| Q40170416 | Oncogenes: Clues to carcinogenesis |
| Q41547255 | Oncogenic genes and human malignancy |
| Q41527398 | Oncoprotein Signalling and Mitosis |
| Q40554557 | Onset of direct 17-beta estradiol effects on proliferation and c-fos expression during oncogenesis of endometrial glandular epithelial cells |
| Q53424015 | Opponents of stem-cell patent win restrictions. |
| Q35368205 | Our changing view of the genomic landscape of cancer |
| Q42820586 | Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. |
| Q38350487 | Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival |
| Q51459248 | Paper-based microreactor array for rapid screening of cell signaling cascades. |
| Q40660881 | Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene |
| Q46262049 | Point mutation in c-HA-ras oncogene in normal and abnormal cells |
| Q37347232 | Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue |
| Q36981182 | Presence of a Kirsten Murine Sarcoma Virus ras Oncogene in Cells Transformed by 3-Methylcholanthrene |
| Q34598085 | Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly(ADP ribose) polymerase |
| Q64058272 | Pro-apoptotic and pro-proliferation functions of the JNK pathway of Drosophila: roles in cell competition, tumorigenesis and regeneration |
| Q38193520 | Prospects for MEK inhibitors for treating cancer. |
| Q36888692 | Purification and characterization of human H-ras proteins expressed in Escherichia coli |
| Q36284491 | RAS genes and growth control in Saccharomyces cerevisiae |
| Q37602305 | RAS in cellular transformation and senescence |
| Q55036584 | RAS oncogenes: the first 30 years. |
| Q40124496 | RETRACTED: A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern |
| Q40139945 | RNA-tumorviruses, oncogenes, and their possible role in human carcinogenesis |
| Q38310978 | Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b |
| Q52721338 | Ras and Rap1: A tale of two GTPases. |
| Q30404024 | Ras history: The saga continues |
| Q34202697 | Ras in cancer and developmental diseases |
| Q29615405 | Ras oncogenes: split personalities |
| Q35062420 | Ras redux: rethinking how and where Ras acts. |
| Q34973413 | Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy |
| Q30486899 | Recessive mechanisms of malignancy |
| Q35607598 | Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene |
| Q35693730 | Regional chromosomal localization of N-ras, K-ras-1, K-ras-2 and myb oncogenes in human cells |
| Q37970568 | Regulating the regulator: post-translational modification of RAS |
| Q28307013 | Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells |
| Q37690837 | Resistance of human cells to tumorigenesis induced by cloned transforming genes |
| Q24611142 | Retroviral oncogenes: a historical primer |
| Q36752763 | Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia |
| Q64935603 | Rho GTPases-Emerging Regulators of Glucose Homeostasis and Metabolic Health. |
| Q38835846 | STAT3 signaling in immunity |
| Q42507880 | Selection of transformed cells in serum-free media |
| Q41114026 | Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine |
| Q35892127 | Self-renewal and solid tumor stem cells |
| Q53829229 | Short-term activation of the Jun N-terminal kinase pathway in apoptosis-deficient cells of Drosophila induces tumorigenesis. |
| Q28540125 | Short-term resveratrol exposure causes in vitro and in vivo growth inhibition and apoptosis of bladder cancer cells |
| Q40872114 | Signal transduction pathways and their relevance in human astrocytomas |
| Q42804851 | Simultaneous transfer of tumorigenic and metastatic phenotypes by transfection with genomic DNA from a human cutaneous squamous cell carcinoma |
| Q34057932 | Small G-protein networks: their crosstalk and signal cascades. |
| Q36073784 | Small GTP-binding proteins |
| Q24553337 | Small GTPases: versatile signaling switches in plants |
| Q57169171 | Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint |
| Q35115865 | Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins. |
| Q37344230 | Spontaneous activation of a human proto-oncogene |
| Q39583802 | Stat3 activation by Src induces specific gene regulation and is required for cell transformation |
| Q27682798 | Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy |
| Q41077398 | Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange. |
| Q45797728 | Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor |
| Q36598671 | Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus |
| Q28265475 | Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene |
| Q36905370 | Structure and transcription of the cellular homolog (c-myb) of the avian myeloblastosis virus transforming gene (v-myb). |
| Q34708404 | Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. |
| Q33932831 | Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein |
| Q41575589 | Syrian hamster embryo cell lines useful for detecting transforming genes in mouse tumours: detection of transforming genes in X-ray-related mouse tumours |
| Q37780775 | Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas |
| Q38110043 | Targeting molecular aberrations in urothelial carcinoma: are we almost there? |
| Q35832710 | Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys |
| Q33679239 | Targeting protein prenylation for cancer therapy |
| Q36278239 | Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy |
| Q40184081 | The 1984 Walter Hubert lecture. Activation of transforming genes in neoplasms |
| Q24606808 | The Cancer Genome Atlas Pan-Cancer analysis project |
| Q40154134 | The Emerging Genetics of Human Cancer |
| Q53560639 | The Human c- ras 1 H Oncogene: a Mutation in Normal and Neoplastic Tissue from the Same Patient |
| Q35684596 | The N-ras oncogene assigned to the short arm of human chromosome 1. |
| Q40137529 | The Pathogenesis of Oncogenic Avian Retrovirusesxs |
| Q36022146 | The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer |
| Q35670180 | The art and design of genetic screens: mammalian culture cells |
| Q35684048 | The association of transcriptionally active genes with the nuclear matrix of the chicken oviduct |
| Q37808166 | The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication |
| Q37956454 | The current state of oncogenes and cancer: experimental approaches for analyzing oncogenetic events in human cancer |
| Q36419929 | The discovery of HTLV-1, the first pathogenic human retrovirus |
| Q93270879 | The duality of human oncoproteins: drivers of cancer and congenital disorders |
| Q40410235 | The etiology of bladder cancer--are there any new clues or predictors of behavior? |
| Q52724470 | The evolution of bladder cancer genomics: What have we learned and how can we use it? |
| Q30398835 | The experiences of a biochemist in the evolving world of G protein-dependent signaling |
| Q24610004 | The history of tumor virology |
| Q36714886 | The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells |
| Q35264991 | The human c-Ha-ras2 is a processed pseudogene inactivated by numerous base substitutions |
| Q39499415 | The molecular action of platelet-derived growth factor |
| Q28199928 | The molecular biology of cancer |
| Q34519801 | The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence |
| Q42816223 | The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction |
| Q72046869 | The myc oncogene in man and birds |
| Q42811919 | The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein |
| Q36841835 | The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation |
| Q77343239 | The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomas |
| Q33931555 | The presence of bovine papillomavirus type 4 DNA is not required for the progression to, or the maintenance of, the malignant state in cancers of the alimentary canal in cattle |
| Q38840267 | The present and future of genome editing in cancer research |
| Q36080374 | The proliferation of multiple myeloma colonies (MY-CFUc) in vitro is independent of prognosis and is not associated with mutated N- or K-ras alleles in human bone marrow aspirates |
| Q41686658 | The radiosensitivity of human keratinocytes: influence of activated c-H-ras oncogene expression and tumorigenicity |
| Q42367544 | The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis |
| Q38740000 | The renewed battle against RAS-mutant cancers |
| Q36751714 | The role of cellular oncogenes in myogenesis and muscle cell hypertrophy |
| Q34616409 | The role of oncogenes in gastrointestinal cancer |
| Q64232346 | The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity |
| Q40159818 | The tumor phenotype and the human gene map |
| Q26747403 | The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancers |
| Q37632230 | Therapeutic approach to treating patients with BRAF-mutant lung cancer: latest evidence and clinical implications |
| Q38242397 | Therapeutic potential of siRNA and DNAzymes in cancer. |
| Q28266043 | Three different activated ras genes in mouse tumours; evidence for oncogene activation during progression of a mouse lymphoma |
| Q37608532 | Three human transforming genes are related to the viral ras oncogenes |
| Q48225794 | Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V). |
| Q36896137 | Transfection of the EJ rasHa gene into keratinocytes derived from carcinogen-induced mouse papillomas causes malignant progression |
| Q41558670 | Transformation of rat cell by SV40 virus |
| Q36478421 | Transforming activity of DNA extracted from human urological tumours |
| Q40676636 | Transforming activity of DNA fragments from normal human lymphocytes results from spontaneous activation of a c-Ha-ras1 gene |
| Q39511011 | Transforming genes and target cells of murine spleen focus-forming viruses |
| Q37345502 | Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype |
| Q42819175 | Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? |
| Q39813626 | Transforming ras oncogenes and multistage carcinogenesis |
| Q43479536 | Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein |
| Q40139883 | Tumor viruses, oncogenes, and human cancer |
| Q28265486 | Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes |
| Q34253429 | Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus |
| Q37635491 | Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy |
| Q36327439 | Two human c-onc genes are located on the long arm of chromosome 8. |
| Q34070577 | Understanding nuclear receptor function: from DNA to chromatin to the interphase nucleus |
| Q59058134 | Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients |
| Q57295717 | Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes |
| Q38357122 | Vemurafenib for the treatment of BRAF mutant metastatic melanoma |
| Q33846198 | Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease |
| Q24653900 | Viruses associated with human cancer |
| Q70015595 | c-rasH and ornithine decarboxylase are induced by oestradiol-17 beta in the mouse uterine luminal epithelium independently of the proliferative status of the cell |
Search more.